Oncology & Cancer

Wording used may affect thyroid cancer patients' anxiety, choices

(HealthDay)—The terminology used to describe small papillary thyroid cancers (PTCs) may affect patients' anxiety levels and treatment choices, according to a study published online Aug. 23 in JAMA Otolaryngology-Head & ...

Oncology & Cancer

Drop the C-word to reduce anxiety and overtreatment, say experts

Medical researchers are calling for the word 'cancer' to be dropped from some doctor-patient conversations in a bid to reduce patient anxiety and harm from over treatment.The appeal in today's BMJ follows mounting evidence ...

Oncology & Cancer

Pre-cancerous—warning sign or cause for panic?

It might be a spot, lump, bump or polyp you've found suspicious or bothersome enough to ask a doctor to have a look at. The doctor sends what she has excised for testing and tells you it's "pre-cancerous". But what exactly ...

Medical research

Research toward healing the hearts of children with Duchenne

After a progressive weakening of the muscles takes away their motor skills, and then their abilities to stand and walk, most males with Duchenne muscular dystrophy die of heart and respiratory failure in their 20s.

Immunology

Macular degeneration linked to aging immune cells

As people age, their immune systems age, too. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk for age-related macular degeneration, a major cause ...

Oncology & Cancer

Making headway in infant leukemia research

Around 600 children under the age of 15 are diagnosed with leukaemia each year in Germany. The effects are especially dramatic if this severe illness develops at birth or shortly afterwards. Research carried out at the Division ...

Oncology & Cancer

Emerging from mastectomy

When she was diagnosed with breast cancer, Margaret Pelikan had two goals: to get rid of the disease and to feel normal afterward. Her team at Mayo Clinic helped her accomplish both.

Oncology & Cancer

New system finds and targets vulnerabilities in lung cancer cells

Genetic changes that help lung cancer thrive also make it vulnerable to a promising experimental drug, according to a study led by researchers from Perlmutter Cancer at NYU Langone Health, and published online October 2 in ...

page 9 from 34